Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹10.59
Market cap
₹237.5 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 47.3×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:39 IST BSE
Other Announcement

Nectar Lifesciences Other Announcement

Nectar Lifesciences Limited announced a change in its corporate office address, moving to Godrej Eternia in Chandigarh effective September 15, 2026.

20:37 IST BSE
Other Announcement

Nectar Lifesciences Other Announcement

Nectar Lifesciences shifted its registered office within Dera Bassi, Punjab. This administrative change does not affect the company's operations or statutory registrations.

10:20 IST BSE
Other Announcement

Nectar Lifesciences Other Announcement

Nectar Lifesciences Ltd submitted its Annual Secretarial Compliance Report for FY2026. The report highlighted a ₹0.02 Crore fine paid to exchanges for a past delay in filing FY2025 financial results due to the Chairman's health. The auditor confirmed the company has since rectified the default and complied with other SEBI regulations.

Value
₹0.02 Cr